However, we acknowledge several limits: (1) a Heidelberg OCT-A database is lacking from the device, which is compensated by the constitution of a control group; and (2) the size of the study population does not allow subgroup analyses of etiology (MS, anti-AQP4, anti-MOG). The gene discussed is AQP4; the disease is myeloid sarcoma.